HCRN Directory

Carcinoma of Unknown Primary

HCRN-CUP16-268

Single-arm phase 2 study to examine pembrolizumab and concurrent radiation to induce an abscopal effect in patients with previously treated carcinoma of unknown primary (CUP16-268)

Status

Closed

Cancer Types

Carcinoma of Unknown Primary

Locations